Is auxiliuspharma.com Safe? Security Analysis for Auxilius Pharma S.A.
https://auxiliuspharma.comCheck if auxiliuspharma.com is a scam or legitimate. Free security scan and reviews.
Below Healthcare avg (65)
10,000+
Domains scanned
500+
Security teams trust us
EveryPay
Secure checkout
Instant
Reports delivered
Get the professional PDF report for auxiliuspharma.com
Export this security analysis as a professional PDF document, receive it via email, and access marketing intelligence data including contact emails and phone numbers. One-time purchase for lifetime access.
PDF Report & Export
PDF download, email delivery, unlock code
Marketing Intelligence
Contact emails, phone numbers & warm leads
Plan Comparison
| Feature | PDF Report | Marketing+ |
|---|---|---|
| Full security analysis | ||
| Professional PDF export | ||
| Email delivery | ||
| Lifetime access + unlock code | ||
| Contact emails & phones | — | |
| Marketing outreach data | — |
Already purchased?
Order summary
Digital reports are delivered immediately after payment. By continuing you acknowledge the withdrawal waiver described in our Returns & Refunds policy.
Secure payments processed via EveryPay. Prices in EUR; Incl. 21% VAT.
SEQ SIA
Lastadijas 12 k-3, Riga, Latvia, LV-1050
Reg. No. 40203410806 • VAT LV40203410806
Support: guard@offseq.com • +371 2256 5353
AI Summary
Auxilius Pharma S.A. is a small emerging pharmaceutical company specializing in cardiovascular health, particularly focusing on value-added medicines such as AUX-001, an antianginal agent designed to improve patient outcomes and reduce hospitalizations. The company targets healthcare providers, payors, and patients with cardiovascular conditions, positioning itself as an innovative player in the pharmaceutical market with a clear mission and product focus. The website reflects a professional and consistent brand image with clear business information and contact details. Technically, the website is built using modern technologies including React and Gatsby, hosted on A2 Hosting, and employs Tailwind CSS for styling. It demonstrates good performance, mobile optimization, and basic accessibility features. SEO is well addressed with proper meta tags and structured content. Google Tag Manager is used for analytics and tracking, with a cookie consent banner ensuring user privacy compliance. From a security perspective, the site uses HTTPS with good SSL configuration but lacks explicit security headers and dedicated security or incident response policies. No vulnerabilities or suspicious content were detected. Privacy compliance is well addressed with a privacy policy and cookie consent mechanism, though GDPR-specific details could be enhanced. The WHOIS data shows consistent domain registration aligned with the business founding date, no privacy protection, and registrar locks, indicating legitimacy. Overall, the website presents a low-risk profile with good business credibility and technical maturity. Strategic recommendations include implementing security headers, publishing a security policy or vulnerability disclosure, enhancing accessibility, and continuous monitoring of third-party scripts to maintain security and compliance.
Detected Technologies
10 urgent findings need attention
10 high
- + 2 more findings in the full report below
Keep auxiliuspharma.com under constant watch
Guard tracks your live infrastructure daily: certificate expiry, DNS & mail authentication drift, uptime changes, subdomain inventory, and unexpected tracker or content shifts. A full timeline captures every diff so you can prove remediation and spot regressions instantly.
Security drift alerts
Risk score drops, new high-severity issues, and header hardening gaps
Compliance watch
GDPR / NIS2 posture changes with governance evidence snapshots
Infrastructure surface
Unexpected open services, SSL expiry, DNS & email authentication changes
Content & tracker intelligence
Marketing tech shifts, analytics drift, and AI recommendation updates
Cancel anytime. Alerts sent to the contacts you choose. Unlock the full report to view historical timelines and alerts.
Security Headers
4 findings
65/100
GDPR Compliance
3 findings
68/100
NIS2 Compliance
9 findings
2/100
Email Security
3 findings
85/100
🧠AI Business Intelligence
Technology stack, business insights, and market analysis powered by AI.
Business Intelligence
Market & Strategic Analysis
Auxilius Pharma operates in the healthcare sector, focusing on cardiovascular pharmaceuticals with a niche in value-added medicines. Their flagship product, AUX-001, targets chronic stable angina, addressing unmet medical needs with a unique mechanism of action and convenient dosing. The company appears to be in early growth stages, founded in 2019, with a clear market positioning as an innovative pharmaceutical provider. Their business model centers on pharmaceutical development and commercialization, targeting healthcare providers and payors. The website and LinkedIn presence indicate efforts to build credibility and engage stakeholders. No direct revenue streams or partnerships were explicitly identified from the website content. The company maintains a professional digital presence with clear communication of mission and product benefits, supporting growth and market penetration.
Security Posture Analysis
Comprehensive Security Assessment
The website demonstrates a moderate security posture with HTTPS enabled and SSL configured properly, ensuring encrypted communications. However, the absence of key security headers such as Content Security Policy (CSP), X-Frame-Options, and HSTS reduces defense-in-depth. No explicit security policies or incident response contacts are published, which could hinder rapid response to security incidents. The cookie consent banner indicates awareness of privacy regulations, but GDPR compliance details are basic. No vulnerabilities or exposed sensitive data were detected in the HTML content. The use of Google Tag Manager introduces a moderate tracking footprint, which should be monitored for privacy compliance. Overall, the security posture is adequate for a small healthcare company website but can be improved by adopting best practices and transparency in security policies.
Strategic Recommendations
Priority Actions for Security Improvement
Implement comprehensive HTTP security headers including CSP, HSTS, X-Frame-Options, and X-Content-Type-Options.
✨Observations
AI-powered comprehensive website and business analysis.
AI-Enhanced Website Analysis
Business Insights
Auxilius Pharma S.A.
Auxilius Pharma is an emerging pharmaceutical company focusing on Value-Added Medicines, dedicated to addressing unmet medical needs in cardiovascular health by transforming and enhancing existing medications.
good
consistent
Technical Stack
fast
good
basic
good
Security Assessment
- HTTPS enabled
- Cookie consent banner implemented
- No exposed sensitive data in HTML
Analytics & Tracking
Advertising & Marketing
Website Quality Assessment
Key Observations
Professional pharmaceutical company website focused on cardiovascular health.
Get this report delivered to your inbox
Receive a summary of the auxiliuspharma.com security findings by email. Quick and easy to share with decision makers.
🛡️Security Headers
HTTP security headers analysis and recommendations.
Security Headers
HTTP security headers analysis
Missing Content-Security-Policy header
HIGHControls resources the browser is allowed to load
Weak Referrer-Policy configuration
LOWCurrent value: "same-origin"
Missing Permissions-Policy header
MEDIUMControls browser features and APIs
Sensitive data may be cached
LOWCache-Control header should include "no-store" for sensitive pages
👤GDPR Compliance
Privacy and data protection assessment under GDPR regulations.
GDPR Compliance
Privacy and data protection assessment
No Cookie Policy found
HIGHGDPR requires clear information about cookie usage
No Data Protection Officer mentioned
LOWLarge organizations may need to designate a DPO under GDPR
Privacy policy may not be GDPR compliant
MEDIUMPrivacy policy lacks explicit GDPR compliance elements
GDPR Compliance Analysis
🛡️NIS2 Compliance
Network & Information Security Directive compliance assessment.
NIS2 Compliance
Network & Information Security Directive
No information security framework found
HIGHNIS2 requires documented cybersecurity and information security measures
No vulnerability disclosure policy
MEDIUMNIS2 encourages coordinated vulnerability disclosure
No security policy documentation found
HIGHNIS2 requires documented cybersecurity governance and risk management
No incident response procedures found
HIGHNIS2 requires documented incident response and business continuity plans
No business continuity planning found
MEDIUMNIS2 emphasizes operational resilience and business continuity
No security contact information
HIGHNIS2 requires clear incident reporting channels
No vulnerability reporting mechanism
MEDIUMClear vulnerability reporting supports coordinated disclosure
No NIS2 reference found
LOWConsider explicitly mentioning NIS2 compliance efforts
Critical sector without clear security compliance
HIGHDetected sectors: transport, health, digital
Need this report as a PDF?
Download the complete auxiliuspharma.com security analysis as a professional PDF. Share it with your team, clients, or stakeholders.
📧Email Security
SPF, DKIM, and DMARC validation and email security assessment.
Email Security
SPF, DKIM, and DMARC validation
No BIMI Record
LOWBIMI displays brand logos in email clients
No MTA-STS Policy
MEDIUMMTA-STS enforces TLS for email delivery
No TLS-RPT Record
LOWTLS-RPT provides reporting for email TLS issues
SPF Details
DKIM Selectors Found
🏆SSL/TLS Security
Certificate validity and encryption analysis.
SSL/TLS Security
Certificate validity and encryption analysis
Weak Protocols Supported
HIGHServer supports weak protocols: TLSv1.1
OCSP Stapling Not Enabled
LOWOCSP stapling improves performance and privacy
Certificate Transparency Not Implemented
LOWCertificate is not logged in Certificate Transparency logs
SSL Certificate Expires Within 90 Days
MEDIUMSSL certificate expires in 41 days
Weak SSL Key Length
HIGHSSL certificate uses 256-bit key, which is considered weak
Partial SSL/TLS Assessment
LOWCompleted 3 of 4 security checks due to time constraints
Protocol Support
OCSP Status
📊DNS Health
DNS configuration and security assessment.
DNS Health
DNS configuration and security assessment
Unregistered MX Record
HIGHMX record points to unregistered domain: auxiliuspharma-com.mail.protection.outlook.com
DNSSEC Not Enabled
MEDIUMDNSSEC is not configured for this domain
CAA Records Not Configured
LOWCertificate Authority Authorization (CAA) records not found
No DMARC Record
MEDIUMDMARC policy not configured
Domain Registration Details
DNS Records
DNSSEC Status
SPF Analysis
⚡Network Security
Port scanning and network exposure analysis.
Network Security
Port scanning and network exposure analysis
Good Network Security Posture
LOWNo unnecessary services detected on common risky ports
How does auxiliuspharma.com compare?
See how auxiliuspharma.com stacks up against similar websites in the same industry.
🔧Technical Analysis
Detailed technical findings and analysis from AI assessment.
Technical Analysis
Comprehensive security assessment findings
Additional Findings
Download the auxiliuspharma.com report as PDF
Get the complete analysis in a shareable PDF format, delivered instantly to your email with lifetime access.
PDF Report & Export
PDF download, email delivery, unlock code
Marketing Intelligence
Contact emails, phone numbers & warm leads
Plan Comparison
| Feature | PDF Report | Marketing+ |
|---|---|---|
| Full security analysis | ||
| Professional PDF export | ||
| Email delivery | ||
| Lifetime access + unlock code | ||
| Contact emails & phones | — | |
| Marketing outreach data | — |
Already purchased?
Order summary
Digital reports are delivered immediately after payment. By continuing you acknowledge the withdrawal waiver described in our Returns & Refunds policy.
Secure payments processed via EveryPay. Prices in EUR; Incl. 21% VAT.
SEQ SIA
Lastadijas 12 k-3, Riga, Latvia, LV-1050
Reg. No. 40203410806 • VAT LV40203410806
Support: guard@offseq.com • +371 2256 5353
Scan your own website
Liked the auxiliuspharma.com report? Run the same comprehensive security analysis on your domain — free, instant, and no sign-up required.
Or browse our directory of >10,000 scanned websites.
How did we do?
Your feedback directly shapes our roadmap. Rate the quality of this report, leave an optional comment, and let us know if you want our security specialists to follow up.
What others say about auxiliuspharma.com
Share your experience to help others make informed decisions. We verify every review by email and publish it once our moderation team approves it.
Community rating
—out of 5
0 reviews published